BioVie to Present New Bezisterim Findings in Parkinson’s Disease and Long COVID at the 2026 American Neurological Association Annual Meeting
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq rise as tech stocks gain ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: BIVI) | Delayed: 1.68 +0.31 (22.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.37 | 52 Week High | $0.40 | |||
| Open | $1.43 | 52 Week Low | $0.17 | |||
| Day High | $2.66 | P/E | N/A | |||
| Day Low | $1.40 | EPS | $0.00 | |||
| Volume | 12,229,502 | |||||
